Literature DB >> 24944737

Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66.

Vivek Kumar1, Ashwini K Banala1, Erick G Garcia1, Jianjing Cao1, Thomas M Keck1, Alessandro Bonifazi1, Jeffery R Deschamps2, Amy Hauck Newman1.   

Abstract

The improved chiral synthesis of the selective dopamine D3 receptor (D3R) antagonist (R)-N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)-3-hydroxybutyl)1H-indole-2-carboxamide (( R )-PG648) is described. The same chiral secondary alcohol intermediate was used to prepare the enantiomers of a 3-F-benzofuranyl analogue, BAK 2-66. The absolute configurations of the 3-F enantiomers were assigned from their X-ray crystal structures that confirmed retention of configuration during fluorination with N,N-diethylaminosulfur trifluoride (DAST). ( R )-BAK2-66 showed higher D3R affinity and selectivity than its (S)-enantiomer; however, it had lower D3R affinity and enantioselectivity than ( R )-PG648. Further, importance of the 4-atom linker length between the aryl amide and 4-phenylpiperazine was demonstrated with the 4-fluorobutyl-product (8).

Entities:  

Keywords:  DAST; asymmetric catalysis; dopamine; enantioselectivity

Year:  2014        PMID: 24944737      PMCID: PMC4060923          DOI: 10.1021/ml500006v

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

1.  Asymmetric catalysis with water: efficient kinetic resolution of terminal epoxides by means of catalytic hydrolysis.

Authors:  M Tokunaga; J F Larrow; F Kakiuchi; E N Jacobsen
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

2.  Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.

Authors:  Isabelle Boileau; Doris Payer; Sylvain Houle; Arian Behzadi; Pablo M Rusjan; Junchao Tong; Diana Wilkins; Peter Selby; Tony P George; Martin Zack; Yoshiaki Furukawa; Tina McCluskey; Alan A Wilson; Stephen J Kish
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

3.  N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.

Authors:  Ashwini K Banala; Benjamin A Levy; Sameer S Khatri; Cheryse A Furman; Rebecca A Roof; Yogesh Mishra; Suzy A Griffin; David R Sibley; Robert R Luedtke; Amy Hauck Newman
Journal:  J Med Chem       Date:  2011-05-02       Impact factor: 7.446

4.  Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.

Authors:  Ellen Y T Chien; Wei Liu; Qiang Zhao; Vsevolod Katritch; Gye Won Han; Michael A Hanson; Lei Shi; Amy Hauck Newman; Jonathan A Javitch; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-11-19       Impact factor: 47.728

Review 5.  Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspective.

Authors:  Fabrizio Micheli
Journal:  ChemMedChem       Date:  2011-03-18       Impact factor: 3.466

Review 6.  Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Authors:  Christian A Heidbreder; Amy H Newman
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 7.  Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design.

Authors:  Thomas M Keck; Caitlin Burzynski; Lei Shi; Amy Hauck Newman
Journal:  Adv Pharmacol       Date:  2014

8.  Molecular determinants of selectivity and efficacy at the dopamine D3 receptor.

Authors:  Amy Hauck Newman; Thijs Beuming; Ashwini K Banala; Prashant Donthamsetti; Katherine Pongetti; Alex LaBounty; Benjamin Levy; Jianjing Cao; Mayako Michino; Robert R Luedtke; Jonathan A Javitch; Lei Shi
Journal:  J Med Chem       Date:  2012-06-07       Impact factor: 7.446

9.  A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors.

Authors:  Mayako Michino; Prashant Donthamsetti; Thijs Beuming; Ashwini Banala; Lihua Duan; Thomas Roux; Yang Han; Eric Trinquet; Amy Hauck Newman; Jonathan A Javitch; Lei Shi
Journal:  Mol Pharmacol       Date:  2013-09-23       Impact factor: 4.436

10.  N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.

Authors:  Amy Hauck Newman; Peter Grundt; George Cyriac; Jeffrey R Deschamps; Michelle Taylor; Rakesh Kumar; David Ho; Robert R Luedtke
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

View more
  9 in total

1.  Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R).

Authors:  Vivek Kumar; Amy E Moritz; Thomas M Keck; Alessandro Bonifazi; Michael P Ellenberger; Christopher D Sibley; R Benjamin Free; Lei Shi; J Robert Lane; David R Sibley; Amy Hauck Newman
Journal:  J Med Chem       Date:  2017-02-10       Impact factor: 7.446

2.  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.

Authors:  Amy E Moritz; R Benjamin Free; Warren S Weiner; Emmanuel O Akano; Disha Gandhi; Ara Abramyan; Thomas M Keck; Marc Ferrer; Xin Hu; Noel Southall; Joseph Steiner; Jeffrey Aubé; Lei Shi; Kevin J Frankowski; David R Sibley
Journal:  J Med Chem       Date:  2020-05-12       Impact factor: 7.446

3.  The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective Agonists.

Authors:  Francisco O Battiti; Sophie L Cemaj; Adrian M Guerrero; Anver Basha Shaik; Jenny Lam; Rana Rais; Barbara S Slusher; Jeffery R Deschamps; Greg H Imler; Amy Hauck Newman; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-07-01       Impact factor: 7.446

4.  Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.

Authors:  Vivek Kumar; Alessandro Bonifazi; Michael P Ellenberger; Thomas M Keck; Elie Pommier; Rana Rais; Barbara S Slusher; Eliot Gardner; Zhi-Bing You; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  J Med Chem       Date:  2016-08-10       Impact factor: 7.446

5.  2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts.

Authors:  Amy Hauck Newman; Francisco O Battiti; Alessandro Bonifazi
Journal:  J Med Chem       Date:  2019-09-24       Impact factor: 7.446

6.  Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.

Authors:  Thomas M Keck; William S John; Paul W Czoty; Michael A Nader; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-03-31       Impact factor: 7.446

7.  High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice.

Authors:  Comfort A Boateng; Oluyomi M Bakare; Jia Zhan; Ashwini K Banala; Caitlin Burzynski; Elie Pommier; Thomas M Keck; Prashant Donthamsetti; Jonathan A Javitch; Rana Rais; Barbara S Slusher; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-07-23       Impact factor: 7.446

8.  A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder.

Authors:  Ewa Galaj; Guo-Hua Bi; Benjamin Klein; Briana Hempel; Anver Basha Shaik; Emma S Gogarnoiu; Jacob Friedman; Jenny Lam; Rana Rais; John F Reed; Shelley H Bloom; Tracy L Swanson; Jennifer L Schmachtenberg; Amy J Eshleman; Aaron Janowsky; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  Neuropsychopharmacology       Date:  2022-07-25       Impact factor: 8.294

9.  Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D3 Receptor Antagonists and Partial Agonists.

Authors:  Anver Basha Shaik; Vivek Kumar; Alessandro Bonifazi; Adrian M Guerrero; Sophie L Cemaj; Alexandra Gadiano; Jenny Lam; Zheng-Xiong Xi; Rana Rais; Barbara S Slusher; Amy Hauck Newman
Journal:  J Med Chem       Date:  2019-10-15       Impact factor: 7.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.